Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Tectonic Therapeutic

Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein
From Tectonic Therapeutic
Via GlobeNewswire
Tickers TECX
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights
From Tectonic Therapeutic
Via GlobeNewswire
Tickers TECX
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
From Tectonic Therapeutic
Via GlobeNewswire
Tickers TECX
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
From Tectonic Therapeutic
Via GlobeNewswire
Tickers TECX
Tectonic Therapeutic to Participate in September Investor Conferences
From Tectonic Therapeutic
Via GlobeNewswire
Tickers TECX
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights
From Tectonic Therapeutic
Via GlobeNewswire
Tickers TECX
Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45
From Tectonic Therapeutic
Via GlobeNewswire
Tickers TECX
Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million
From Tectonic Therapeutic
Via Business Wire
Tickers TECX
Tectonic Therapeutic Strengthens Leadership Team
From Tectonic Therapeutic
Via Business Wire
Fierce Biotech Names Tectonic Therapeutic as One of Its “Fierce 15” Biotech Companies of 2021
From Tectonic Therapeutic
Via Business Wire
Tectonic Therapeutic Named an “Endpoints 11” Winner
From Tectonic Therapeutic
Via Business Wire
Tectonic Therapeutic Appoints Marcella Ruddy, MD as Chief Medical Officer
From Tectonic Therapeutic
Via Business Wire
Tectonic Therapeutic Appoints Peter McNamara, PhD Senior Vice President, Head of Research
From Tectonic Therapeutic
Via Business Wire
Tectonic Therapeutic Launches with $80 Million Series A Financing to Transform the Discovery of Novel G-Protein Coupled Receptor (GPCR)-Targeted Therapies
From Tectonic Therapeutic
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS